Patent Assignment
Reel/Frame 018590/0620
Assignment of Assignor's Interest
Recorded: 2006-12-06
Pages: 34
Assignor
BRX MAGYARORSZAG RT
Executed: 2004-10-04
Assignee
CYTRX CORPORATION
11726 SAN VICENTE BLVD., SUITE 650, LOS ANGELES, CALIFORNIA, 90049
Covered Properties
(9)
Novel 0-(3-Amino-2-Hydroxypropyl)-Hydroximic Acid Halides and Process for Preparing the Same
Patent:
5,147,879 →
Application:
07/499,318 →
Hydroximic Acid Derivatives, Pharmaceutical Compositions Containing Them, and Processes for Preparing the Same
Patent:
5,919,796 →
Application:
08/737,168 →
Hydroxylamine Derivatives Useful for Enhancing the Molecular Chaperon Production and the Preparation Thereof
Patent:
6,653,326 →
Application:
08/860,582 →
Anti-Ischaemic Hydroxylamine Derivatives and Pharmaceutical Compositions
Patent:
6,002,002 →
Application:
08/914,115 →
Pharmaceutical Products for Curing and Preventing Illnesses Connected with the Malfunction of Vascular Endothelial Cells
Patent:
6,143,741 →
Application:
09/230,941 →
Optically Active Pyridyl-4H-1,2,4-Oxadiazine Derivative and Its Use in the Treatment of Vascular Diseases
Patent:
6,384,029 →
Application:
09/762,949 →
N-[2-Hydroxy-3-(1-Piperidinyl)Propoxy}Pyridine-1-Oxide-3-Carboximidoyl Chlorine and Its Use in the Treatment of Unsulin Resistance
Patent:
6,649,628 →
Application:
09/913,263 →
Pyridine-1-Oxide Derivative, and Process for Its Transformation into Pharmaceutically Effective Compounds
Carboxamidine Derivatives and Their Use in the Treatment of Vascular Diseases
Related Assignments
(18)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignors Interest.
Jul 16, 1990
From: NAGY, PETER L.; BALAZS, BELA; BOROSS, MARIA; SZILBEREKY, JENO
To: BIOREX KUTATO-FEJLESZTO KFT.,
Reel/Frame 005605/0166 →
Assignment of Assignor's Interest
Jan 19, 1999
From: BIOREX KUTATO-FEFLESZTO KFT.
To: BIOREX KUTATO ES FEJLESZTO RT
Reel/Frame 009737/0489 →
Assignment of Assignor's Interest
Oct 25, 1999
From: UROGDI, LASZLO; MARVANYOS, EDE; JEDNAKOVITS, ANDREA; RADVANYNE, HEGEDUS ERZSEBET
To: BIOREX RESEARCH & DEVELOPMENT CO.
Reel/Frame 010328/0324 →
Assignment of Assignor's Interest
Dec 6, 1999
From: JEDNAKOVITS, ANDREA; UROGDI, LASZLO; MARVANYOS, EDE; BARABAS, MIHALY
To: BIOREX KUTATO ES FEJLESZTO RT
Reel/Frame 010439/0958 →
Assignment of Assignor's Interest
May 16, 2000
From: VIGH, LASZLO; NAGY, PETER LITERATI; SZILBEREKY, JENO; UROGDI, LASZLO
To: BIOREX RESEARCH & DEVELOPMENT CO.
Reel/Frame 010836/0148 →
Assignment of Assignor's Interest
May 15, 2001
From: JEDNAKOVITS, ANDREA; UROGDI, LASZLO; DENES, LASZLO; KURUCZ, ISTVAN
To: BIOREX KUTATO ES FEJLESZTO RT.
Reel/Frame 011809/0110 →
Assignment of Assignor's Interest
Dec 18, 2001
From: KURTHY, MARIA; BIRO, KATALIN; NAGY, KAROLY; UROGDI, LASZLO
To: BIOREX KUTATO ES FEJLESZTO RT.
Reel/Frame 012374/0696 →
Assignment of Assignor's Interest
Jul 25, 2003
From: UROGDI, LASZLO; JEGESNE CSAKAI, ZITA; GRUBER, LAJOS; OTVOS, LASZLO
To: BIOREX KUTATO ES FEJLESZTO RT.
Reel/Frame 014317/0612 →
Assignment of Assignor's Interest
Jul 15, 2005
From: BIROREX KUTATO ES FEJLESZTO RT.
To: CYTRX CORPORATION
Reel/Frame 016784/0135 →
Assignment of Assignor's Interest
Aug 29, 2005
From: BIOREX KUTATÓ ÉS FEJLESZTÖ RT. ("V.A."); BRX RESEARCH AND DEVELOPMENT COMPANY LTD
To: CYTRX CORPORATION
Reel/Frame 016460/0725 →
Assignment of Assignor's Interest
Mar 21, 2012
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 027901/0269 →
Patent Assignment Agreement
Jun 26, 2013
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 030694/0809 →
Change of Name
Apr 11, 2018
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 045911/0992 →
Security Interest
Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest
Jul 6, 2022
From: ORPHAZYME A/S
To: KEMPHARM, INC.
Reel/Frame 060592/0646 →
Assignment of Assignor's Interest
Jul 6, 2022
From: KEMPHARM, INC.
To: KEMPHARM DENMARK A/S
Reel/Frame 060592/0595 →
Change of Name
Oct 12, 2022
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 061659/0984 →
Release of Security Interest
Apr 4, 2024
From: KREOS CAPITAL VI (UK) LIMITED
To: ZEVRA DENMARK A/S (F/K/A KEMPHARM DENMARK A/S, SUCCESSOR IN INTEREST TO ORPHAZYME A/S)
Reel/Frame 067007/0706 →